Blue Trust Inc’s Blueprint Medicines BPMC Stock Holding History

Blue Trust Inc’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-113	Closed	-$10K	–	2466
2025 Q1	$10K	Hold	113	–	–	﹤0.01%	1893
2024 Q4	$9.86K	Buy	113 +48	+74%	+$4.4K	﹤0.01%	1900
2024 Q3	$7.01K	Buy	65 +3	+5%	+$298	﹤0.01%	2311
2024 Q2	$5.88K	Buy	+62	New	+$6.21K	﹤0.01%	2138
2024 Q1	–	Sell	-9	Closed	–	–	2237
2023 Q4	$0	Buy	+9	New	+$583	﹤0.01%	2497
2022 Q3	–	Sell	-5	Closed	–	–	2096
2022 Q2	$0	Buy	+5	New	+$293	﹤0.01%	1890

Other funds holding BPMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Trust Inc's BPMC Position: Q2 2025 in Review

Blue Trust Inc sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 113 shares — an estimated $10K sold.

Blue Trust Inc first reported a position in BPMC in Q2 2022 and held it in 6 quarters. The position peaked at $10K in Q1 2025. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

Blue Trust Inc reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
Blue Trust Inc sold 113 Blueprint Medicines shares in Q2 2025, an estimated $10K.
Blue Trust Inc first reported a position in Blueprint Medicines in Q2 2022 and held it in 6 quarters.
Blue Trust Inc's Blueprint Medicines position peaked at $10K in Q1 2025.
354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Blue Trust Inc's 13F filing for Q2 2025, filed 24 Jul 2025.